Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Molecular classification of hepatocellular adenoma: A single-center experience

Shen XY, Hu XG, Kim YB, Kim MN, Hong SY, Kim BW, Wang HJ

BACKGROUNDS/AIMS: Hepatocellular adenoma (HCA) is a rare benign tumor that has a risk of malignant transformation into hepatocellular carcinoma (HCC) and bleeding. The aim of this study was to analyze...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can we delineate preoperatively the right and ventral margins of caudate lobe of the liver?

Shen XY, Wang HJ, Kim BW, Hong SY, Kim MN, Hu XG

PURPOSE: Complete removal of the caudate lobe, which is sometimes necessary, is accomplished via isolated caudate lobectomy or hepatectomy that includes the caudate lobe. It is impossible, however, to confirm...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma

Kim IG, Hu XG, Wang HJ, Kim BW, Hong SY, Shen XY

PURPOSE: Although many staging systems have been proposed for hepatocellular carcinoma (HCC), there is no globally accepted system due to the extreme heterogeneity of the disease. We aimed to compare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Feasibility of Right Posterior Sector Graft in the Adult Living Donor Liver Transplantation

Bang JB, Kim BW, Wang HJ, Kim TG, Sim J, Hu XG

BACKGROUND: The aim of this study is to evaluate the feasibility of living donor liver transplantation (LDLT) using an right posterior sector (RPS) graft selected by liver volumetry of living...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Surgical treatment for hepatocellular carcinoma with bile duct invasion

Hu XG, Mao W, Hong SY, Kim BW, Xu WG, Wang HJ

PURPOSE: There is still some debate on surgical procedures for hepatocellular carcinoma (HCC) patients with bile duct tumor thrombi (BDTT, Ueda type 3 or 4). What is adequate extent of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy

Hu XG, Mao W, Park YK, Xu WG, Kim BW, Wang HJ

PURPOSE: The systemic inflammation biomarker, Neutrophil-to-Lymphocyte Ratio (NLR), has been reported as one of the adverse prognostic factors for hepatocellular carcinoma (HCC) patient. The purpose of this study was to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
18F-fluorodeoxyglucose PET/CT as an independent predictor for patients with hepatocellular carcinoma combined with major portal vein tumor thrombus

Hu XG, Shen XY, Nan JN, Kim IG, Yoon JK, Hong SY, Kim MN, Kim BW, Wang HJ

Purpose: Hepatocellular carcinoma (HCC) patients with major portal vein tumor thrombosis (mPVTT) complications were generally characterized by extremely poor prognoses. The aim of this study was to explore the role...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr